Goldman Sachs’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-74,835
Closed -$299K 6164
2023
Q1
$299K Buy
+74,835
New +$330K ﹤0.01% 5110
2022
Q3
Sell
-23,340
Closed -$89K 6634
2022
Q2
$89K Buy
23,340
+4,249
+22% +$27.1K ﹤0.01% 5895
2022
Q1
$135K Buy
+19,091
New +$134K ﹤0.01% 6012

Other funds holding TGAN

Goldman Sachs's TGAN Position: Q2 2023 in Review

Goldman Sachs sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2023, closing a stake of 74,835 shares — an estimated $299K sold.

Goldman Sachs first reported a position in TGAN in Q1 2022 and held it in 3 quarters. The position peaked at $299K in Q1 2023. 41 funds tracked by Wall St. Rank hold TGAN as of Q2 2023.

  • Goldman Sachs reported no remaining Transphorm, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 74,835 Transphorm, Inc. Common Stock shares in Q2 2023, an estimated $299K.
  • Goldman Sachs first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Goldman Sachs's Transphorm, Inc. Common Stock position peaked at $299K in Q1 2023.
  • 41 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.